Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review

Aim. To analyze the efficacy, safety and pharmacoeconomic indicators of ocrelizumab in adult patients with primary progressive multiple sclerosis (PPMS). Methods. An information search was conducted in the databases Embase, PubMed, Cochrane and eLibrary.ru. The levels of evidence were determined in...

Full description

Bibliographic Details
Main Authors: D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, K. A. Kokushkin
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-07-01
Series:Качественная клиническая практика
Subjects:
окрелизумаб
эффективность
безопасность
систематический обзор
первично-прогрессирующий рассеянный склероз
анти-в-клеточная терапия
моноклональные антитела
Online Access:https://www.clinvest.ru/jour/article/view/405

Internet

https://www.clinvest.ru/jour/article/view/405

Similar Items